American Century
Advanced Medical Impact Equity Fund
a sub-fund of Nomura Funds Ireland plc
American Century Advanced Medical Impact Equity Fund
a sub-fund of Nomura Funds Ireland
Investment Approach
The American Century Advanced Medical Impact Equity Fund focuses on doing well while doing good. The team seeks to invest in innovative health care companies positioned for sustainably high growth. As the portfolio companies attain their fundamental growth objectives, they should also create a positive impact on society.
Philosophy
We believe an investment strategy can offer both dedication to performance and an opportunity to create positive impact in the world. The health care investment universe has an unprecedented level of innovation, which may lead to opportunities for significant value creation. In addition, as these companies attain their fundamental objectives, they also have potential to create a meaningful impact on society.
Good health care equity investments first start with good businesses. A good business is one with a competitive advantage that is demonstrated by the presence or the potential of above-average profitability, combined with opportunities of scaling the business that result in a sustained, high fundamental growth rate. These good health care businesses become potential investment opportunities when they demonstrate improving fundamentals, price momentum and attractive valuations.
Fund Highlights
- A focus on achieving a positive social impact alongside a financial return.
- Innovative health care investments aligned with the United Nations Sustainable Development Goal 3 (UN SDG-3): Ensure healthy lives and promote wellbeing for all at all ages.
- Investment team composed of former industry practitioners and other significant skillsets.
Potential significant risks
International investing involves special risk considerations, including economic and political conditions, inflation rates and currency fluctuations. Investing in emerging markets may accentuate these risks. Historically, small-cap stocks have been more volatile than the stocks of larger, more established companies.
For additional strategy information, please visit the American Century Investments® website. (Please note that the link will access a website for contents of which we take no responsibility and to which our data protection rules do not apply.)
To learn about our strategic relationship with American Century Investments, please visit our Strategic Partnership page.
| Investment Objective | To achieve long-term capital growth through investment in an actively managed portfolio of equity securities of companies engaged in the health care sector. |
| Fund Size | USD 5.7 million (as at 31.05.2022) |
| Investment Company | Nomura Asset Management U.K. Ltd. |
| Fund Managers |
Michael Li, PhD, Senior Portfolio Manager, American Century Investments |
| Launch Date | 22.01.2021 |
| Base Currency | USD |
| Benchmark | MSCI World Healthcare Index |
| Domicile | Ireland (Nomura Funds Ireland Plc) |
| Lead ISINs | I USD: IE00BMH6QM89 I GBP: IE00BMH6QP11 A USD: IE00BMH6QF13 F USD: IE00BMH6QJ50 For additional share class information, please contact us. |
| Fund | Monthly Factsheet | ||||
|---|---|---|---|---|---|
| Class I USD |
|
||||
| Class A USD | |||||
| Class F USD |
For a full list of available share class documents including KIIDs, please visit our fund documents page.
The lead share class fund literature is shown first in the above list. If any literature is not available in the above list for the share class you are invested in/interested in, please contact NAMupdates@nomura-asset.eu
Nomura Funds Ireland plc is an open-ended investment company with variable capital, incorporated in Ireland on 13th April, 2006 under the Act with registration number 418598. The Fund has been authorised by the Central Bank as an UCITS pursuant to the UCITS Regulations. The Fund is structured as an umbrella fund consisting of different Sub-Funds each comprising one or more Classes. The Fund has segregated liability between each of its Sub-Funds.
Full information on the presented fund, which is relevant for an investment decision can be found in the fund´s most recent sales prospectus, the Key Investor Information Documents (KIIDs) and annual and semi-annual reports. The KIIDs are available in the official language of the countries in which the fund is registered for distribution. This fund displays higher volatility due to its composition / the techniques used by the fund management, i.e. unit prices can fluctuate upwards or downwards within short periods of time. Performance in the past is no guarantee of future success. There can be no guarantee that the fund´s investment objective will actually be achieved.
A summary of investor rights in English and information on collective redress mechanisms are available at https://www.nomura-asset.co.uk/download/funds/how-to-invest/Summary_of_investor_rights.pdf . Nomura Asset Management U.K. Limited may at any time decide to terminate arrangements it may have made for the marketing of units of a fund in a member state other than its home member state.
